Immunotherapy for recurrent pregnancy loss: "standard of care or buyer beware".
Hill
J A
JA
D000026:Abortion, Habitual / Q000276:immunology* / Q000628:therapy*; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000276:immunology / Q000517:prevention & control; D001241:Aspirin / Q000627:therapeutic use; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods*; D007962:Leukocytes / Q000276:immunology; D011247:Pregnancy; D011374:Progesterone / Q000627:therapeutic use; D013927:Thrombosis / Q000276:immunology / Q000517:prevention & control
D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D011374:Progesterone; D006493:Heparin; D001241:Aspirin